Noga Shem‐Tov

CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice

Sigal Tavor, Isabelle Petit, Svetlana Porozov et al. · Cancer Research · 2004 · 357 citations · Full text

Life Sciences, Cell Biology, Oncology +12

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2005 · 311 citations

Medicine, Hematology, Oncology +16

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2007 · 106 citations

Medicine, Hematology, Immunology +16

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Ana Alarcón Tomás, Joshua Fein, Shalev Fried et al. · Leukemia · 2022 · 102 citations · Full text

Medicine, Hematology, Oncology +13

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

Avichai Shimoni, Nicolaus Kröger, Tatjana Zabelina et al. · Leukemia · 2004 · 100 citations

Medicine, Geriatric Medicine, Hematology +17